PMC:7376974 / 92660-92957 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T439","span":{"begin":22,"end":35},"obj":"Body_part"},{"id":"T440","span":{"begin":89,"end":93},"obj":"Body_part"},{"id":"T441","span":{"begin":97,"end":101},"obj":"Body_part"}],"attributes":[{"id":"A439","pred":"fma_id","subj":"T439","obj":"http://purl.org/sig/ont/fma/fma9825"},{"id":"A440","pred":"fma_id","subj":"T440","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A441","pred":"fma_id","subj":"T441","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"The NM stimulated the immune system generating highly efficient antibodies able to block cell-to-cell infection of herpes virus in vivo (three intramuscular injections in mice every 14 days), increasing the survival rate of immunized mice to 100% against the controls (20% survival, Figure 18).153"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T39","span":{"begin":22,"end":35},"obj":"Body_part"}],"attributes":[{"id":"A39","pred":"uberon_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/UBERON_0002405"}],"text":"The NM stimulated the immune system generating highly efficient antibodies able to block cell-to-cell infection of herpes virus in vivo (three intramuscular injections in mice every 14 days), increasing the survival rate of immunized mice to 100% against the controls (20% survival, Figure 18).153"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1649","span":{"begin":171,"end":175},"obj":"Species"},{"id":"1650","span":{"begin":234,"end":238},"obj":"Species"},{"id":"1655","span":{"begin":102,"end":111},"obj":"Disease"}],"attributes":[{"id":"A1649","pred":"tao:has_database_id","subj":"1649","obj":"Tax:10090"},{"id":"A1650","pred":"tao:has_database_id","subj":"1650","obj":"Tax:10090"},{"id":"A1655","pred":"tao:has_database_id","subj":"1655","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The NM stimulated the immune system generating highly efficient antibodies able to block cell-to-cell infection of herpes virus in vivo (three intramuscular injections in mice every 14 days), increasing the survival rate of immunized mice to 100% against the controls (20% survival, Figure 18).153"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T258","span":{"begin":4,"end":6},"obj":"Disease"},{"id":"T260","span":{"begin":102,"end":111},"obj":"Disease"}],"attributes":[{"id":"A258","pred":"mondo_id","subj":"T258","obj":"http://purl.obolibrary.org/obo/MONDO_0008091"},{"id":"A259","pred":"mondo_id","subj":"T258","obj":"http://purl.obolibrary.org/obo/MONDO_0011603"},{"id":"A260","pred":"mondo_id","subj":"T260","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"The NM stimulated the immune system generating highly efficient antibodies able to block cell-to-cell infection of herpes virus in vivo (three intramuscular injections in mice every 14 days), increasing the survival rate of immunized mice to 100% against the controls (20% survival, Figure 18).153"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T849","span":{"begin":22,"end":35},"obj":"http://purl.obolibrary.org/obo/UBERON_0002405"},{"id":"T850","span":{"begin":89,"end":93},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T851","span":{"begin":97,"end":101},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T852","span":{"begin":122,"end":127},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T853","span":{"begin":290,"end":292},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"}],"text":"The NM stimulated the immune system generating highly efficient antibodies able to block cell-to-cell infection of herpes virus in vivo (three intramuscular injections in mice every 14 days), increasing the survival rate of immunized mice to 100% against the controls (20% survival, Figure 18).153"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T82326","span":{"begin":4,"end":6},"obj":"Chemical"}],"attributes":[{"id":"A59289","pred":"chebi_id","subj":"T82326","obj":"http://purl.obolibrary.org/obo/CHEBI_141423"}],"text":"The NM stimulated the immune system generating highly efficient antibodies able to block cell-to-cell infection of herpes virus in vivo (three intramuscular injections in mice every 14 days), increasing the survival rate of immunized mice to 100% against the controls (20% survival, Figure 18).153"}

{"project":"LitCovid-sentences","denotations":[{"id":"T557","span":{"begin":0,"end":297},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The NM stimulated the immune system generating highly efficient antibodies able to block cell-to-cell infection of herpes virus in vivo (three intramuscular injections in mice every 14 days), increasing the survival rate of immunized mice to 100% against the controls (20% survival, Figure 18).153"}

{"project":"2_test","denotations":[{"id":"32667191-30594660-153409","span":{"begin":294,"end":297},"obj":"30594660"}],"text":"The NM stimulated the immune system generating highly efficient antibodies able to block cell-to-cell infection of herpes virus in vivo (three intramuscular injections in mice every 14 days), increasing the survival rate of immunized mice to 100% against the controls (20% survival, Figure 18).153"}